diltiazem has been researched along with Cardiovascular Diseases in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (36.00) | 18.7374 |
| 1990's | 11 (22.00) | 18.2507 |
| 2000's | 15 (30.00) | 29.6817 |
| 2010's | 6 (12.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, JH; Kang, C; Kang, TS; Kim, DH; Kim, RB; Kim, SC; Lee, DH; Lee, SH; Shin, IW | 1 |
| Baryshnikova, GA; Blochina, OE; Chorbinskayva, SA; Korchazhkina, NB; Maslennikova, OM; Maslovskyi, LV; Stepanova, II; Zverkov, IV | 1 |
| Ezeugo, U; Glasser, SP | 1 |
| Almgren, P; Dahlberg, J; Fava, C; Hedner, T; Kjeldsen, S; Melander, O; Svensson-Färbom, P; Wahlstrand, B | 1 |
| Barrios, V | 1 |
| Dharma, S; Pancholy, S; Patel, T; Radadiya, R; Shah, S; Vyas, C | 1 |
| Agarwal, A; Henkle, JQ; Rehman, A; Yu, SW | 1 |
| Assad, JA; Barretto, R; Braga, SL; da Costa, RL; Feres, F; Mont'Alverne Filho, JR; Pierre, AG; Saleh, MH; Sousa, AG; Sousa, JE; Zago, Ado C | 1 |
| Fukumoto, Y; Ito, A; Shimokawa, H; Yasuda, S | 1 |
| Almgren, P; Färbom, P; Hedner, T; Kjeldsen, S; Lanke, J; Melander, O; Skrtic, S; Wahlstrand, B; Weiss, L | 1 |
| Karlsberg, RP | 2 |
| Ellrodt, AG; Singh, BN | 1 |
| Chew, CY; Ellrodt, G; Singh, BN | 1 |
| Antman, EM; Braunwald, E; Muller, JE; Stone, PH | 2 |
| Antman, EM; Rossi, LP | 1 |
| Aronow, WS; Karlsberg, RP | 1 |
| Fozzard, HA; Schwartz, DJ; Wasserstrom, JA | 1 |
| Aziza, JP; Blanchard, D; Guermonprez, JL; Lancelin, B; Maurice, P | 1 |
| Salerno, SM; Zugibe, FT | 1 |
| Frewin, D; Tonkin, A | 1 |
| Conti, CR | 1 |
| Held, C; Laragh, JH; Messerli, F; Pepine, C; Sleight, P | 1 |
| Furukawa, H; Iwaki, K; Iwasaki, T; Kawakami, M; Matsumura, S; Matsunaga, K; Shimamura, T; Yonetani, Y | 1 |
| Conti, CR; Davies, RF; Deanfield, J; Forman, S; Geller, N; Goldberg, AD; Knatterud, GL; Pepine, CJ; Pratt, C; Sopko, G | 1 |
| Amy, RM; Dolphin, PJ; Graham, SE; Russell, JC | 1 |
| Beach, CL; Ford, DE; Klag, MJ; Mead, LA; Roht, LH | 1 |
| Dahlöf, B; de Faire, U; Hansson, L; Hedner, T; Karlberg, BE; Kjeldsen, SE; Lanke, J; Lindholm, LH; Lund-Johansen, P; Syvertsen, JO | 2 |
| Adelman, A | 1 |
| Achard, JM; Aldigier, JC; Oudart, N | 1 |
| Avanzini, F; Tognoni, G | 1 |
| Bouffandeau, B; Fournier, A; Georgita, A; Oprisiu, R | 1 |
| Kjeldsen, SE; Os, I; Westheim, AS | 1 |
| Ruddy, MC | 1 |
| Hansson, L; Hildebrandt, PR; Kjeldsen, SE; Lund-Johansen, P; Tuxen, CD | 1 |
| Badiali, A; Marrama, P; Pantaleoni, M; Ricci, S; Velardo, A; Zironi, C; Zizzo, G | 1 |
| Tam, IM; Wandres, DL | 1 |
| Djian, J | 1 |
| Brouwer, RM; Bühler, FR; Follath, F | 1 |
| Berman, BA; Ross, RN | 1 |
| Bertelli, A; Mian, M; Palombo, C | 1 |
| Parisi, AF; Strauss, WE | 1 |
| Cromeens, DM; Minor, ST; Rodgers, GP; Swindle, MM | 1 |
| Burgess, CD | 1 |
| Larach, DR; Zelis, R | 1 |
| Hillis, LD; Winniford, MD | 1 |
17 review(s) available for diltiazem and Cardiovascular Diseases
| Article | Year |
|---|---|
[Use of Verapamil and Dilthiasem in treating patients at high cardiovascular risk (review of literature)].
Topics: Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Humans; Verapamil | 2016 |
Clinical benefits versus shortcomings of diltiazem once-daily in the chronotherapy of cardiovascular diseases.
Topics: Angina Pectoris; Calcium Channel Blockers; Cardiovascular Diseases; Delayed-Action Preparations; Diltiazem; Drug Chronotherapy; Humans; Hypertension; Risk Assessment | 2009 |
Clinical applications of slow channel blocking compounds.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood Platelets; Blood Vessels; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Coronary Disease; Coronary Vessels; Diltiazem; Drug Interactions; Electrophysiology; Heart; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; Ischemic Attack, Transient; Nifedipine; Verapamil | 1983 |
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; Cardiovascular Diseases; Clinical Trials as Topic; Cyclic AMP; Diltiazem; Dogs; Electrophysiology; Guinea Pigs; Heart; Heart Conduction System; Humans; Ion Channels; Nifedipine; Pyridines; Sodium; Verapamil | 1980 |
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.
Topics: Benzazepines; Calcium Channel Blockers; Cardiovascular Diseases; Coronary Circulation; Diltiazem; Hemodynamics; Humans; Myocardial Contraction; Nifedipine; Nitrogen; Perhexiline; Piperidines; Pyridines; Regional Blood Flow; Vasodilation; Verapamil | 1980 |
Re-examining the clinical safety and roles of calcium antagonists in cardiovascular medicine.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiovascular Diseases; Coronary Vessels; Diltiazem; Humans; Myocardial Infarction; Myocardial Ischemia; Ventricular Dysfunction; Verapamil | 1996 |
Calcium antagonists and cardiovascular prognosis: a homogeneous group?
Topics: Calcium Channel Blockers; Cardiovascular Diseases; Clinical Trials as Topic; Dihydropyridines; Diltiazem; Humans; Prognosis; Verapamil | 1996 |
The INSIGHT and NORDIL trials: Are calcium antagonists equivalent to established drug therapies for cardiovascular protection?
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Diuretics; Humans; Hypertension; Nifedipine; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
[Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Diltiazem; Humans; Hypertension; Hypolipidemic Agents; Middle Aged; Nifedipine; Prospective Studies; Randomized Controlled Trials as Topic | 2001 |
Calcium-channel blockers and gingival hyperplasia.
Topics: Aged; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Female; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine; Recurrence; Time Factors; Verapamil | 1992 |
Sustained-release diltiazem and prevention of cardiovascular risk in hypertensive patients.
Topics: Cardiovascular Diseases; Delayed-Action Preparations; Diltiazem; Humans; Hypertension; Risk Factors | 1990 |
Review of the cardiovascular adversity of the calcium antagonist beta-blocker combination: implications for antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Drug Therapy, Combination; Heart Conduction System; Hemodynamics; Humans; Hypertension; Nifedipine; Verapamil | 1985 |
Treating coexisting cardiovascular and pulmonary disease with calcium antagonists.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Asthma, Exercise-Induced; Bronchial Spasm; Calcium; Calcium Channel Blockers; Cardiovascular Diseases; Constipation; Diltiazem; Headache; Heart Conduction System; Humans; Ion Channels; Lung Diseases; Lung Diseases, Obstructive; Nifedipine; Verapamil | 1986 |
[Calcium antagonists: accounts on new perspectives of their use and an update on side effects].
Topics: Adult; Animals; Asthma; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Esophageal Achalasia; Female; Humans; Hypertension, Pulmonary; Infant, Newborn; Male; Menstruation Disturbances; Nifedipine; Obstetric Labor, Premature; Pregnancy; Rabbits; Rats; Stomach Ulcer; Verapamil | 1989 |
Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Drug Therapy, Combination; Humans; Nifedipine; Verapamil | 1988 |
Advances in calcium blocker therapy.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Asthma; Blood Platelet Disorders; Calcium; Calcium Channel Blockers; Cardiovascular Diseases; Coronary Disease; Diltiazem; Gastrointestinal Diseases; Heart Failure; Humans; Hypertension; Kinetics; Nifedipine; United States; Vascular Diseases; Verapamil | 1986 |
Calcium antagonists in patients with cardiovascular disease. Current perspectives.
Topics: Angina Pectoris; Angina Pectoris, Variant; Atrial Fibrillation; Atrial Flutter; Benzazepines; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Diltiazem; Drug Interactions; Heart Failure; Humans; Hypertension; Hypertension, Pulmonary; Kinetics; Nifedipine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1985 |
8 trial(s) available for diltiazem and Cardiovascular Diseases
| Article | Year |
|---|---|
A functional variant of the NEDD4L gene is associated with beneficial treatment response with β-blockers and diuretics in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Aged; Alleles; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diltiazem; Endosomal Sorting Complexes Required for Transport; Epithelial Sodium Channels; Female; Genotype; Humans; Hypertension; Male; Middle Aged; Nedd4 Ubiquitin Protein Ligases; Polymorphism, Single Nucleotide; Sodium Chloride Symporter Inhibitors; Treatment Outcome; Ubiquitin-Protein Ligases; Vasodilator Agents | 2011 |
Nitroglycerin plus diltiazem versus nitroglycerin alone for spasm prophylaxis with transradial approach.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Pressure; Cardiovascular Diseases; Diltiazem; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Prospective Studies; Radial Artery; Spasm; Vascular Diseases; Vasoconstriction; Vasodilator Agents | 2012 |
Comparative study of the use of diltiazem as an antispasmodic drug in coronary angiography via the transradial approach.
Topics: Cardiovascular Diseases; Coronary Angiography; Diltiazem; Diuretics, Osmotic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isosorbide; Male; Middle Aged; Parasympatholytics; Radial Artery | 2003 |
Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the nordic diltiazem study.
Topics: Aged; Albuminuria; Antihypertensive Agents; Cardiovascular Diseases; Diltiazem; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Male; Middle Aged; Norway; Prognosis; Risk Factors; Sweden | 2008 |
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; Cardiovascular Diseases; Clinical Trials as Topic; Cyclic AMP; Diltiazem; Dogs; Electrophysiology; Guinea Pigs; Heart; Heart Conduction System; Humans; Ion Channels; Nifedipine; Pyridines; Sodium; Verapamil | 1980 |
Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Atenolol; Calcium Channel Blockers; Cardiopulmonary Bypass; Cardiovascular Diseases; Comorbidity; Diltiazem; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Follow-Up Studies; Humans; Isosorbide Dinitrate; Life Tables; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Nifedipine; Pilot Projects; Prognosis; Risk Factors; Survival Analysis; Treatment Outcome; Vasodilator Agents | 1997 |
Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Diuretics; Female; Humans; Hypertension; Life Tables; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Single-Blind Method; Stroke | 2000 |
Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.
Topics: Adrenergic beta-Antagonists; Aged; Aging; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Prospective Studies; Sex Characteristics; Stroke; Survival Analysis | 2002 |
26 other study(ies) available for diltiazem and Cardiovascular Diseases
| Article | Year |
|---|---|
The effects of intravenous lipid emulsion on prolongation of survival in a rat model of calcium channel blocker toxicity.
Topics: Animals; Antidotes; Arterial Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Disease Models, Animal; Fat Emulsions, Intravenous; Heart Rate; Male; Nicardipine; Poisoning; Rats, Sprague-Dawley; Time Factors | 2015 |
Diltiazem in the treatment of hypertension and ischemic heart disease.
Topics: Antihypertensive Agents; Blood Pressure; Cardiovascular Agents; Cardiovascular Diseases; Diltiazem; Humans; Hypertension; Myocardial Ischemia; Risk Factors | 2011 |
Hyperinsulinemia euglycemia therapy for calcium channel blocker overdose: a case report.
Topics: Blood Pressure; Bradycardia; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Glucose Clamp Technique; Heart Rate; Humans; Hyperinsulinism; Hypoglycemic Agents; Hypotension; Infusions, Intravenous; Insulin; Male; Middle Aged; Poisoning; Prescription Drug Misuse; Psychotic Disorders; Suicide, Attempted; Time Factors; Treatment Outcome | 2012 |
Adult hypertension: reducing cardiovascular morbidity and mortality.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Alcohol Drinking; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Determination; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Complications; Diltiazem; Diuretics; Drug Evaluation; Health Behavior; Humans; Hypertension; Losartan; Obesity; Renal Insufficiency; Sodium; Stroke; Verapamil | 2005 |
Prognostic effects of benidipine in patients with vasospastic angina: comparison with diltiazem and amlodipine.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Diseases; Cohort Studies; Coronary Vasospasm; Dihydropyridines; Diltiazem; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Factors | 2008 |
Welcome--the calcium channel blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Coronary Disease; Diltiazem; Humans; Ion Channels; Lung Diseases; Nifedipine; Tachycardia; Verapamil | 1981 |
Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium; Cardiovascular Diseases; Coronary Disease; Diltiazem; Heart Block; Humans; Ion Channels; Muscle, Smooth, Vascular; Muscles; Myocardial Contraction; Nifedipine; Sodium; Verapamil | 1980 |
Calcium channel blockers for cardiovascular disorders.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Humans; Hypertension; Ion Channels; Nifedipine; Verapamil | 1982 |
Calcium channel blockers. New treatment for cardiovascular disease.
Topics: Adult; Angina Pectoris; Calcium; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Diltiazem; Drug Administration Schedule; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Nifedipine; Verapamil | 1983 |
Calcium channel blockers: indications and limitations 1. Clinical pharmacology and use as antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Biological Availability; Calcium; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Dose-Response Relationship, Drug; Heart Block; Humans; Hypotension; Nifedipine; Verapamil | 1982 |
Therapeutic uses of calcium-blocking agents:verapamil, nifedipine, and diltiazem.
Topics: Benzazepines; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Humans; Nifedipine; Pyridines; Verapamil | 1981 |
[Calcium inhibitors. Current indications in cardiology].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium; Cardiovascular Diseases; Diltiazem; Humans; Nifedipine; Perhexiline; Prenylamine; Verapamil | 1980 |
Calcium channel antagonists. What do the second-generation agents have to offer?
Topics: Arteriosclerosis; Calcium Channel Blockers; Cardiovascular Diseases; Cerebrovascular Disorders; Dihydropyridines; Diltiazem; Heart Failure; Humans; Verapamil | 1994 |
The use of calcium channel blockers in general practice.
Topics: Calcium Channel Blockers; Cardiovascular Diseases; Dihydropyridines; Diltiazem; Family Practice; Female; Humans; Male; Verapamil | 1993 |
Revisiting calcium channel blockers--from basic facts to clinical practice.
Topics: Aged; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Humans; Hypertension; Nifedipine; Verapamil | 1996 |
Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 2. Hypotensive effects in normotensive and hypertensive rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Calcium Channels; Cardiovascular Diseases; Diltiazem; Heart Rate; Hypertension; Hypotension; Kidney Diseases; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Wistar | 1996 |
Cardioprotective and hypolipidemic effects of nisoldipine in the JCR:LA-cp rat.
Topics: Animals; Blood Glucose; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Female; Hypolipidemic Agents; Lipids; Male; Microscopy, Electron, Scanning; Myocardial Contraction; Myocardium; Nifedipine; Nisoldipine; Rats; Rats, Inbred Strains; Sex Characteristics; Time Factors | 1997 |
Feasibility of using recipients of health promotional newsletters for post-marketing surveillance.
Topics: Aged; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Feasibility Studies; Female; Health Promotion; Health Status; Humans; Hypertension; Male; Multivariate Analysis; Periodicals as Topic; Product Surveillance, Postmarketing; Sampling Studies; Surveys and Questionnaires; United States | 2000 |
Is diltiazem as effective as diuretics and beta-blockers in preventing complications from hypertension?
Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Diuretics; Humans; Hypertension; Middle Aged; Norway; Randomized Controlled Trials as Topic; Sweden; Treatment Outcome | 2000 |
INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Middle Aged | 2000 |
INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Humans; Hypertension; Myocardial Infarction; Nifedipine | 2000 |
INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Diuretics; Humans; Hypertension; Middle Aged; Nifedipine | 2000 |
INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Humans; Hypertension; Middle Aged; Nifedipine | 2000 |
Effects of prolonged treatment with diltiazem on pituitary secretion of luteinizing hormone, follicle-stimulating hormone, thyrotropin and prolactin.
Topics: Adult; Cardiovascular Diseases; Diltiazem; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Kinetics; Luteinizing Hormone; Male; Middle Aged; Pituitary Gland; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1992 |
Bretylium and diltiazem in porcine cardiac procedures.
Topics: Animals; Bretylium Compounds; Cardiovascular Diseases; Cardiovascular Surgical Procedures; Diltiazem; Disease Models, Animal; Female; Male; Swine; Swine, Miniature; Ventricular Fibrillation | 1988 |
Calcium channel antagonists--cardiovascular therapy for the eighties?
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Humans; Hypertension; Nifedipine; Verapamil | 1986 |